* Diebold Nixdorf Inc DBD.N DBD is expected to show a
fall in
quarterly revenue when it reports results on February 9.
* The Hudson Ohio-based company is expected to report a
7.3% decrease in revenue to $982.067 million from $1.06 billion
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Diebold Nixdorf Inc
is
for earnings of 38 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Diebold
Nixdorf
Inc is $4, above its last closing price of $2.47.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.18 0.24 -0.12 Missed -149.5
Jun. 30 2022 -0.12 -0.14 0.38 Beat 371.4
Mar. 31 2022 -0.22 -0.21 -1.61 Missed -648.8
Dec. 31 2021 0.56 0.57 0.06 Missed -89.4
Sep. 0.51 0.51 0.34 Missed -33.3
30 2021
Jun. 30 2021 0.28 0.28 0.10 Missed -64.6
Mar. 31 2021 0.18 0.20 0.29 Beat 42.6
Dec. 31 2020 0.36 0.36 0.44 Beat 23.4
This summary was machine generated February 7 at 19:10 GMT. All
figures in US dollars unless otherwise stated